Monday, November 3, 2014
CSL Behring plans $240 million expansion at its Kankakee operations center
A leader in the plasma protein therapeutics industry, CSL Behring plans a $450 million, two-site, global expansion at its production facilities in Kankakee, Illinois, and Melbourne, Australia.